Production of recombinant protein therapeutics in cultivated mammalian cells
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Cultivated mammalian cells have become the dominant system for the production of recombinant proteins for clinical applications because of their capacity for proper protein folding, assembly and post-translational modification. Thus, the quality and efficacy of a protein can be superior when expressed in mammalian cells versus other hosts such as bacteria, plants and yeast. Recently, the productivity of mammalian cells cultivated in bioreactors has reached the gram per liter range in a number of cases, a more than 100-fold yield improvement over titers seen for similar processes in the mid-1980s. This increase in volumetric productivity has resulted mainly from improvements in media composition and process control. Opportunities still exist for improving mammalian cell systems through further advancements in production systems as well as through vector and host cell engineering.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Advances in cell engineering, process control, and media composition are credited with improving the volumetric yield of cell culture bioprocesses, making biopharmaceutical manufacturing more cost-effective and practical [8].”
From The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing (2022) · cites this paper as [8]
In the citing paper
“Chinese hamster ovary (CHO) cells are one of the main cell lines used in the production of recombinant therapeutics (Wurm, 2004; see Grillberger et al., 2009 for examples of proteins produced in CHO cells).”
From Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing (2010) · cites this paper as Wurm, 2004
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451 · cited 1×
“In 1973, Graham and van der Eb showed that exposing cells to nanoparticles of DNA and calcium phosphate makes possible DNA transfer into cultivated mammalian cell”
BackgroundEpigenetic Codes for Heterochromatin Formation and Silencing
Richards, E. J., & Elgin, S. C. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00644-x · Cited by 871
Umaña, P., Jean–Mairet, J., Moudry, R., Amstutz, H., & Bailey, J. E. (1999) · Nature Biotechnology · doi:10.1038/6179 · Cited by 764
How introns influence and enhance eukaryotic gene expression
Le Hir, H., Nott, A., & Moore, M. J. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00052-5 · Cited by 734
Bebbington, C. R., Renner, G., Thomson, S., King, D., Abrams, D., & Yarranton, G. T. (1992) · Nature Biotechnology · doi:10.1038/nbt0292-169 · Cited by 462 · cited 1×
“At a concentration of 10–100 μM MSX, resistant clones can be identified in selected NS0 cell populations that have amplified the transgene complex containing the GS gene and the desired gene(s) of interes”
BackgroundGenetic and physical linkage of exogenous sequences in transformed cells
Perucho, M., Hanahan, D., & Wigler, M. (1980) · Cell · doi:10.1016/0092-8674(80)90178-6 · Cited by 455 · cited 1×
“Nuclear ligases assure the covalent joining of individual plasmid DNA molecule”
BackgroundExpression of recombinant plasmids in mammalian cells Is enhanced by sodium butyrate
Gorman, C. M., Howard, B. H., & Reeves, R. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.21.7631 · Cited by 367 · cited 1×
“Another way to inhibit silencing is to block deacetylation of histones using butyrat”
BackgroundSilencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9
Mutskov, V., & Felsenfeld, G. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600013 · Cited by 296
Kim, S. J., Kim, N. S., Ryu, C. J., Hong, H. J., & Lee, G. M. (1998) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19980405)58:1<73::aid-bit8>3.0.co;2-r · Cited by 220 · cited 1×
“Thus, it might be advantageous to omit selective drugs once promising clonal cell lines have been identifie”
BackgroundLarge-scale transient expression in mammalian cells for recombinant protein production
Wurm, F., & Bernard, A. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)80027-5 · Cited by 203
Self-citation
Research works printed but not linked: 1
- Gorman, C.M., Howard, B.H. & Reeves, R. Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate. Nucleic Acids Res. 11, 7631–7648 (1983). · DOI · Paper page
Cited by
Items 801–900 of 1,007
Prevato, M., Ferlenghi, I., Bonci, A., Uematsu, Y., Anselmi, G., Giusti, F., Bertholet, S., Legay, F., Telford, J. L., Settembre, E. C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135474 · Cited by 25
“Eukaryotic expression systems like insect cells [16–18] and yeast [19, 20] have already been exploited for the recombinant NA expression, although mammalian cells still remain the preferred expression systems because of their capacity to fold properly, assemble and post-translationally modify complex proteins [21].”
BackgroundNiklas, J., Priesnitz, C., Rose, T., Sandig, V., & Heinzle, E. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3526-6 · Cited by 25
Ihling, N., Munkler, L. P., Paul, R., Berg, C., Reichenbächer, B., Kadisch, M., Lang, D., & Büchs, J. (2022) · Biotechnology Journal · doi:10.1002/biot.202100677 · Cited by 23
Das, P. K., Sahoo, A., & Veeranki, V. D. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2022.107969 · Cited by 23
Generic Chemometric Models for Metabolite Concentration Prediction Based on Raman Spectra
Yousefi‐Darani, A., Paquet‐Durand, O., von Wrochem, A., Claßen, J., Traenkle, J., Mertens, M., Snelders, J., Chotteau, V., Mäkinen, M., Handl, A., et al. (2022) · Sensors · doi:10.3390/s22155581 · Cited by 24
“For over 30 years now, Chinese hamster ovary (CHO) cells have been used in the production of recombinant protein pharmaceuticals [1].”
BackgroundHertel, O., Neuß, A., Busche, T., Brandt, D., Kalinowski, J., Bahnemann, J., & Noll, T. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1010719 · Cited by 25
“Chinese hamster ovary (CHO) cells are the most important cell-based system for biopharmaceutical production, accounting for 70% of all recombinant proteins (Wurm, 2004; Walsh, 2018; Oosting, 2019).”
BackgroundAntibody Fc-chimerism and effector functions: When IgG takes advantage of IgA
Cottignies-Calamarte, A., Tudor, D., & Bomsel, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1037033 · Cited by 26
Lee, K. H., Tsutsui, T., Honda, K., Asano, R., Kumagai, I., Ohtake, H., & Ōmasa, T. (2013) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2013.05.032 · Cited by 25
Capito, F., Bauer, J., Rapp, A., Schröter, C., Kolmar, H., & Stanislawski, B. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.24950 · Cited by 26
“…to 0.1 g L 1 25 years ago as well as rising economic pressure require the need for enhanced purification methods with higher yield and throughput compared to the performance of current chromatography-based systems (Birch and Onakunle, 2005; Kelley, 2009; Sommerfeld and Strube, 2005; Wurm, 2004).”
MethodInfluentialOptimizing plant transporter expression in Xenopus oocytes
Feng, H., Xia, X., Fan, X., Xu, G., & Miller, T. (2013) · Plant Methods · doi:10.1186/1746-4811-9-48 · Cited by 23
“It is widely accepted that optimized codons help to achieve faster translation rates and high accuracy in bacteria, yeast and mammalian cells [24-28,34] and we now show this has advantages for plant genes in Xenopus oocytes too.”
BackgroundMcLean, M. D., Almquist, K. C., Niu, Y., Kimmel, R., Lai, Z., Schreiber, J. R., & Hall, J. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00366-07 · Cited by 32
“However, full-length tetrameric monoclonal antibodies (MAbs) cannot be produced in this way and are thus typically produced for the pharmaceutical industry in bioreactors utilizing mammalian cell lines, such as Chinese hamster ovary (CHO) cells (55).”
Pfizenmaier, J., Junghans, L., Teleki, A., & Takors, R. (2016) · Biotechnology Journal · doi:10.1002/biot.201500606 · Cited by 26
Ho, S. C. L., Koh, E. Y. C., Soo, B. P. C., Mariati, Chao, S., & Yang, Y. (2016) · BMC Biotechnology · doi:10.1186/s12896-016-0300-y · Cited by 25
“Chinese hamster ovary (CHO) cells transfected with plasmid vectors carrying the required gene are used to produce some of these recombinant products [1, 2].”
BackgroundGrowth Rate Changes in CHO Host Cells Are Associated with Karyotypic Heterogeneity
Baik, J. Y., & Lee, K. H. (2017) · Biotechnology Journal · doi:10.1002/biot.201700230 · Cited by 25
Caron, A. L., Biaggio, R. T., & Swiech, K. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7312-5_6 · Cited by 24
Concomitant consumption of glucose and lactate: A novel batch production process for CHO cells
Martínez‐Monge, I., Comas, P., Triquell, J., Casablancas, A., Lecina, M., Paredes, C. J., & Cairó, J. J. (2019) · Biochemical Engineering Journal · doi:10.1016/j.bej.2019.107358 · Cited by 24
Trummer, E., Ernst, W., Hesse, F., Schriebl, K., Lattenmayer, C., Kunert, R., Vorauer‐Uhl, K., Katinger, H. W. D., & Müller, D. (2008) · Biotechnology Journal · doi:10.1002/biot.200800038 · Cited by 31
“Numerous techniques have been established to isolate high producers, including the widely used cloning by limiting dilution in multi-well plates [1] and even advanced high-throughput screening/selection sysTranscriptional profiling of phenotypically different Epo-Fc”
Wagstaff, J. L., Masterton, R. J., Povey, J. F., Smales, C. M., & Howard, M. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077195 · Cited by 27
“biotherapeutic proteins now in the clinic [1].”
Feed development for fed‐batch CHO production process by semisteady state analysis
Khattak, S. F., Xing, Z., Kenty, B. M., Koyrakh, I., & Li, Z. J. (2009) · Biotechnology Progress · doi:10.1002/btpr.362 · Cited by 27
“10 pg/cell/day).(1) All of these improvements led to an increase in the accumulated yield from 50 mg/L in 1986 to 5 g/L in 2004.”
BackgroundLanza, A. M., Dyess, T. J., & Alper, H. S. (2012) · Biotechnology Journal · doi:10.1002/biot.201200034 · Cited by 23
“Stable transgene expression is required for biotechnology applications such as therapeutics production in mammalian cells [1, 2].”
BackgroundSchmidt, C., Wehsling, M., Mignon, M. L., Wille, G., Rey, Y. P., Schnellbaecher, A., Zabezhinsky, D., Fischer, M., & Zimmer, A. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27755 · Cited by 23
“%) are produced in cultured Chinese hamster ovary (CHO) cells, due to their capacity to process complex glycosylation, and other human‐like posttranslational modifications (Grilo & Mantalaris, 2019; McAtee et al., 2014; Wurm, 2004).”
BackgroundZhang, Y., Huang, Y., Jin, X., Chen, J., Peng, L., Wang, D.-L., Li, Y., Yao, X.-Y., Liao, J., He, J., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01044-7 · Cited by 22
“Furthermore, due to low integration frequency, it is quite time-consuming, establishing a stable cell may take up to 6 months [30, 31].”
BackgroundIntein-mediated one-step purification of Escherichia coli secreted human antibody fragments
Wu, W., Miller, K. D., Coolbaugh, M. J., & Wood, D. W. (2010) · Protein Expression and Purification · doi:10.1016/j.pep.2010.12.004 · Cited by 25
Sood, N., Chaudhary, D. K., Pradhan, P. K., Verma, D. K., Swaminathan, T. R., Kushwaha, B., Punia, P., & Jena, J. K. (2015) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-015-9891-1 · Cited by 22
“The main purposes of transfection are to study the function of genes or gene products, by enhancing or inhibiting specific gene expression in cells, and to produce recombinant proteins in the cells (Wurm 2004).”
BackgroundChen, C., Le, H., & Goudar, C. T. (2015) · Biochemical Engineering Journal · doi:10.1016/j.bej.2015.11.013 · Cited by 24
Chromatographic Techniques in the Downstream Processing of Proteins in Biotechnology
Freitag, R. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-733-4_25 · Cited by 22
Morbioli, G. G., Mazzu-Nascimento, T., Aquino, A., Cervantes, C. A. C., & Carrilho, E. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2016.06.019 · Cited by 25
Traylor, M. J., Tchoudakova, A., Lundquist, A. M., Gill, J. E., Boldog, F. L., & Tangarone, B. S. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b02895 · Cited by 23
Orbitally shaken shallow fluid layers. I. Regime classification
Alpresa, P., Sherwin, S. J., Weinberg, P. D., & van Reeuwijk, M. (2018) · Physics of Fluids · doi:10.1063/1.4996916 · Cited by 22
Lin, H., Du, Q., Li, Q., Wang, O., Wang, Z., Elowsky, C. G., Liu, K., Zhang, C., Chung, S., Duan, B., et al. (2018) · Biomaterials Science · doi:10.1039/c8bm01095a · Cited by 23
Keller, B.-M., Maier, J., Weldle, M., Segan, S., Traenkle, B., & Rothbauer, U. (2019) · Antibodies · doi:10.3390/antib8010010 · Cited by 23
“Notably, the site of integration has a major effect on the expression levels of the transgene summarized as positioning effect [38].”
BackgroundTellier, M., & Chalmers, R. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.06.006 · Cited by 23
Design and assessment of TRAP-CSP fusion antigens as effective malaria vaccines
Lu, C., Song, G., Beale, K., Yan, J., Garst, E., Feng, J., Lund, E., Catteruccia, F., & Springer, T. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0216260 · Cited by 22
“293S GnTI- cells [27] and Expi293F cells (Thermo Fisher Scientific) were cultured in suspension [28] in serum-free Ex-Cell 293 medium (Sigma) and Expi293 medium (Thermo Fisher Scientific), respectively.”
MethodNa-butyrate sustains energetic states of metabolism and t-PA productivity of CHO cells
McMurray-Beaulieu, V., Hisiger, S., Durand, C., Perrier, M., & Jolicœur, M. (2009) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2009.03.001 · Cited by 22
Fallot, S., Naya, R. B., Hiéblot, C., Mondon, P., Lacazette, É., Bouayadi, K., Kharrat, A., Touriol, C., & Prats, H. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp716 · Cited by 22
“Moreover, this method, involving the use of only one plasmid, seems more reproducible than co-transfection of two plasmids in various ratios (4) because this technique could easily be biased by (i) various transfection efficiencies in transient experiments, (ii) extrapolation for stable transfections and (iii) chromos…”
Jiang, L., & Marcus, R. K. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2016.11.065 · Cited by 22
Biologically Triggered Delivery of EGF from Polymer Fiber Patches
Kim, S.-E., Lee, P. W., & Pokorski, J. K. (2017) · ACS Macro Letters · doi:10.1021/acsmacrolett.7b00212 · Cited by 23
Rhodes, K. E., Clark, I. B., Zatcoff, M., Eustaquio, T., Hoyte, K. L., & Koller, M. R. (2007) · Methods in cell biology · doi:10.1016/s0091-679x(06)82010-8 · Cited by 26
Morales, J. F., Morin, T. J., Yu, B., Tatsuno, G. P., O’Rourke, S. M., Theolis, R., Mesa, K. A., & Berman, P. W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554089 · Cited by 21
“Transfections were carried out with polyethyleneimine, and the supernatant was collected on day 3 or day 4 (55).”
MethodSingle-use bioreactors for microbial cultivation
Oosterhuis, N. M. G., Neubauer, P. B., & Junne, S. G. (2013) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.13.19 · Cited by 23
Monoclonal Antibody Expression in Mammalian Cells
Zhang, R. Y., & Shen, W. D. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-974-7_20 · Cited by 23
Zhang, W., Liu, X., Tang, H., Zhang, X., Zhou, Y., Li, F., Wang, H., Tan, W., & Zhao, L. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10744-3 · Cited by 22
“The low product titer could be attributed to (a) shorter culture duration, hence the reduced integral viable cell concentration (IVCC) and (b) the sharp decrease in qmAb, as these are the two main factors affecting process titers (Wurm 2004).”
BackgroundStadermann, A., Gamer, M., Fieder, J., Lindner, B., Fehrmann, S., Schmidt, M. J., Schulz, P., & Gorr, I. H. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.28012 · Cited by 24
“Furthermore, transgene expression is considered to be directly influenced by the epigenetic state of the integration site where modifications such as DNA methylation may lead to a variable accessibility for the transcription machinery (Kim et al., 2011; Wurm, 2004).”
BackgroundLu, W., Zhao, Z., Huang, Y., & Wang, B. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.01.108 · Cited by 24
Zhu, H., Liu, Y., Yi, X., Zhu, C., Fu, Y., Huang, Z., Zhu, K., Zhang, W., Hou, H., Sun, C., et al. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213229 · Cited by 23
Niazi, S. K. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070918 · Cited by 24
“…cell substrate and expression construct backbone refer to strategies in biotechnology and pharmaceutical manufacturing where a consistent and standardized upstream process is applied to produce various biological products using the same foundational cell substrate and expression construct [32].”
BackgroundHeparin Promotes Suspension Adaptation Process of CHO–TS28 Cells by Eliminating Cell Aggregation
Li, L., Qin, J., Feng, Q., Tang, H., Liu, R., Xu, L., & Chen, Z. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9306-1 · Cited by 21
“control [5].”
Hackl, M., Jadhav, V., Klanert, G., Karbiener, M., Scheideler, M., Grillari, J., & Borth, N. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2013.12.018 · Cited by 23
Integration-free and stable expression of FVIII using a human artificial chromosome
Kurosaki, H., Hiratsuka, M., Imaoka, N., Iida, Y., Uno, N., Kazuki, Y., Ishihara, C., Yakura, Y., Mimuro, J., Sakata, Y., et al. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.88 · Cited by 22
Exploiting Nucleotide Composition to Engineer Promoters
Grabherr, M. G., Pontiller, J., Mauceli, E., Ernst, W., Baumann, M., Biagi, T., Swofford, R., Russell, P. H., Zody, M. C., Palma, F. D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020136 · Cited by 23
“the Chinese hamster ovary (CHO) cell line being a widely used system for EPO, Interferon-b, Factor VIII, IX, etc [1–3].”
Rapid construction of transgene-amplified CHO cell lines by cell cycle checkpoint engineering
Lee, K. H., Onitsuka, M., Honda, K., Ohtake, H., & Ōmasa, T. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-4923-9 · Cited by 22
Lau, E. C., Kong, S., McNulty, S., Entwisle, C., McIlgorm, A., Dalton, K. A., & Hoare, M. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.24865 · Cited by 21
Walther, C. G., Whitfield, R., & James, D. C. (2015) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-015-1945-z · Cited by 25
“CHO cells have been used since 1986 as production vehicle [4, 5] in large-scale biopharmaceutical production due to their capability to produce high protein concentrations, a good consistency in product characteristics [5, 6] in combination with their ability to produce highly N-glycosylated proteins [7, 8].”
BackgroundTrang, H. K., Schadock‐Hewitt, A. J., Jiang, L., & Marcus, R. K. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.02.024 · Cited by 21
Tracking the Evolution of Transiently Transfected Individual Cells in a Microfluidic Platform
Vitor, M. T., Sart, S., Barizien, A., de la Torre, L. G., & Baroud, C. N. (2018) · Scientific Reports · doi:10.1038/s41598-018-19483-y · Cited by 23
“The volume of lipoplexes corresponded to approximately 2–10 × 107 particles/μL (Supplementary Information 2); (3) once the chamber is filled the flow of cells/lipoplex solution is stopped and FC-40/RAN inserted at a flow rate increasing from 5 to 50 μL min−1 to push the cells/lipoplexes solution towards the exit.”
BackgroundDownstream Process Design, Scale-Up Principles, and Process Modeling
Lacki, K. M., Joseph, J. R., & Eriksson, K. O. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-100623-8.00032-3 · Cited by 21
Yang, H., Wang, J.-X., Zhao, M.-L., Zhu, J.-W., Zhang, M., Wang, Z.-Y., Gao, Y., Zhu, W., & Lu, H.-L. (2019) · Biotechnology Letters · doi:10.1007/s10529-019-02702-5 · Cited by 13
“Contributing to their desirable post-translational modification abilities, mammalian cells are dominant hosts for the production of recombinant therapeutic proteins (Wurm 2004; Zhu 2012).”
BackgroundFaravelli, S., Campioni, M., Palamini, M., Canciani, A., Chiapparino, A., & Forneris, F. (2021) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3998 · Cited by 21
“…modifications (PTMs) of proteins, and presently large-volume cultures of mammalian cells constitute a well-established methodology to obtain milligram-to-gram quantities of recombinant proteins (Wurm, 2004; Durocher et al., 2007; Chaudhary et al., 2011; Dyson, 2016; Arena et al., 2018).”
BackgroundMicrobial Expression Systems and Manufacturing from a Market and Economic Perspective
Meyer, H., & Diego, R. (2012) · InTech eBooks · doi:10.5772/29417 · Cited by 26
Enhanced protein production by engineered zinc finger proteins
Reik, A., Zhou, Y., Collingwood, T. N., Warfe, L., Bartsevich, V. V., Kong, Y., Henning, K. A., Fallentine, B. K., Zhang, L., Zhong, X., et al. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21304 · Cited by 22
Thomsson, E., Persson, L., Grahn, A., Snäll, J., Ekblad, M., Brunhage, E., Svensson, F. R., Jern, C., Hansson, G. C., Bäckström, M., et al. (2011) · Journal of Virological Methods · doi:10.1016/j.jviromet.2011.04.014 · Cited by 21
Aydin, H., Azimi, F. C., Cook, J. D., & Lee, J. E. (2012) · Journal of Visualized Experiments · doi:10.3791/4041 · Cited by 25
Ho, S. C. L., & Yang, Y. (2014) · Biotechnology Letters · doi:10.1007/s10529-014-1523-4 · Cited by 26
“Mammalian cells, such as Chinese hamster ovary (CHO) cells, human embryonic kidney cells (HEK293) and murine lymphoid cell lines, are commonly used for production of safe and effective biologics (Ho et al. 2013; Wurm 2004).”
BackgroundSong, M., Raphaelli, K., Jones, M. L., Aliabadizadeh, K., Leung, K. M., Crowley, D., Hughes, B. S., Mahler, S. M., Gray, P. P., Huang, E. P., et al. (2011) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.2618 · Cited by 25
Amribt, Z., Dewasme, L., Wouwer, A. V., & Bogaerts, P. (2014) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-014-1136-2 · Cited by 26
“Monoclonal antibodies (MAb) are currently used for many diagnostic and therapeutic applications (for instance in the treatment of leukemia, Crohn’s disease or transplant rejection) [1–3].”
Munzer, D. G., Ivarsson, M., Usaku, C., Habicher, T., Šoóš, M., Morbidelli, M., Pistikopoulos, E. N., & Mantalaris, A. (2014) · Biochemical Engineering Journal · doi:10.1016/j.bej.2014.10.013 · Cited by 23
Boost Protein Expression through Co-Expression of LEA-Like Peptide in Escherichia coli
Ikeno, S., & Haruyama, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082824 · Cited by 21
“For practical reasons, and in the light of recent development of peptide/protein drugs (biologics), attention has focused particularly on the efficiency of production of recombinant protein, and various host cells have been examined with the aim of achieving efficient production of such protein [1],[2],[3],[4],[5].”
BackgroundTao, G., Shi, T., Tang, X., Duszynski, D. W., Wang, Y., Li, C., Suo, J., Tian, X., Liu, X., & Suo, X. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00002 · Cited by 21
“As the plasmid was randomly integrated into the parasite’s genome, the site of integration may affect the transcription rate of the gene of interest (27).”
BackgroundJérôme, V., Thoring, L., Salzig, D., Kubick, S., & Freitag, R. (2017) · Engineering in Life Sciences · doi:10.1002/elsc.201700005 · Cited by 21
“Their complex nature predestines the BMPs for production in mammalian hosts, such as Chinese Hamster Ovary (CHO) cells [5], in particular since material produced in E.”
BackgroundMonoclonal antibodies: a morphing landscape for therapeutics
Nicolaides, N. C., Sass, P. M., & Grasso, L. (2006) · Drug Development Research · doi:10.1002/ddr.20149 · Cited by 21
Kunert, R., & Casanova, E. (2013) · Bioengineered · doi:10.4161/bioe.24060 · Cited by 24
“Indeed, one of the most important issues is the choice of the expression vector to generate the producer cell line.(1) In principle, an ideal expression vector should fulfill the following criteria: (1) expression should be independent of the integration site into the host genome, (2) expression should not be silenced…”
BackgroundLing, W. L. W. (2015) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.15.8 · Cited by 20
Bertrand, V., Vogg, S., Villiger, T. K., Stettler, M., Broly, H., Šoóš, M., & Morbidelli, M. (2018) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2018.04.015 · Cited by 22
Ebihara, T., Masuda, A., Takahashi, D., Hino, M., Mon, H., Kakino, K., Fujii, T., Fujita, R., Ueda, T., Lee, J. M., et al. (2021) · Molecular Biotechnology · doi:10.1007/s12033-021-00373-0 · Cited by 22
“Cultured mammalian cells also provide a platform for producing recombinant antibodies in large scale, but the screening of cell lines with high-expression and the modulation of culture conditions are time-consuming (minimum 12 months) [25].”
BackgroundIhling, N., Munkler, L. P., Berg, C., Reichenbächer, B., Wirth, J., Lang, D., Wagner, R., & Büchs, J. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.725498 · Cited by 20
“…ovary (CHO cells), mass transfer characteristics, shake flask cultivation, oxygen transfer rate, time-resolved monitoring INTRODUCTION Complex therapeutic proteins are dominantly produced using mammalian cell cultivation with Chinese hamster ovary (CHO) cells as the preferred host (Wurm, 2004).”
BackgroundLignocellulosic biomass-based glycoconjugates for diverse biotechnological applications
Reis, C. E. R., Milessi, T. S., Ramos, M. D. N., Singh, A. K., Mohanakrishna, G., Aminabhavi, T. M., Kumar, P. S., & Chandel, A. K. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108209 · Cited by 24
Guessous, G., Blake, L., Bui, A., Woo, Y., & Manzanarez, G. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c00145 · Cited by 20
Secretory expression of Porcine Circovirus Type 2 capsid protein in Pichia pastoris
Silva, J. G., Coimbra, E. C., de Jesus, A. L. S., Mariz, F. C., Silva, K. M. G., Lobato, Z. I. P., Campos, A. C., Coutinho, L. C. A., de Castro, R. S., & de Freitas, A. C. (2014) · Journal of Virological Methods · doi:10.1016/j.jviromet.2014.07.021 · Cited by 21
Tassew, N. G., Charish, J., Chestopalova, L., & Monnier, P. P. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5385-08.2009 · Cited by 20
“In recent years, small recombinant antibodies, such as single-chain Fv (scFv) fragments (Bird et al., 1988; Skerra and Plückthun, 1988), have been developed and expressed in mammalian cells (Meissner et al., 2001; Wurm, 2004) and very recently in living organisms (Zuber et al., 2008).”
BackgroundZhong, X., Kieras, E., Sousa, E. A., D’Antona, A. M., Baber, J. C., He, T., Desharnais, J., Wood, L. D., Luxenberg, D. P., Stahl, M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.417717 · Cited by 20
“Ever since human tissue plasminogen activator was first approved by the Food and Drug Administration in 1986, cultivated mammalian cells have become important host cells for the production of recombinant proteins for clinical applications, due to their relevant post-translationalmodifications and stringent protein qua…”
BackgroundBrunke, C., Lohse, S., Derer, S., Peipp, M., Boross, P., Kellner, C., Beyer, T. D., Dechant, M., Royle, L., Liew, L. P., et al. (2013) · mAbs · doi:10.4161/mabs.26396 · Cited by 20
“This preferential use of IgG antibodies is likely caused by well-established production and purification technologies and knowledge about the relevant safety issues assessable for regulatory agencies.(2) Another benefit of their use includes an elongated serum half-life caused by the interaction of IgG antibodies with…”
BackgroundRyle, J. P., McDonnell, S., Glennon, B., & Sheridan, J. T. (2013) · Applied Optics · doi:10.1364/ao.52.000c78 · Cited by 20
Ansary, R. H., Rahman, M. M., Awang, M. B., Katas, H., Hadi, H. A., Mohamed, F., Doolaanea, A. A., & Kamaruzzaman, Y. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0710-3 · Cited by 21
Farzan, P., & Ierapetritou, M. (2016) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2016.11.037 · Cited by 21
Bodenberger, N. E., Kubiczek, D. H., Trösch, L., Gawanbacht, A., Wilhelm, S., Tielker, D., & Rosenau, F. (2017) · Scientific Reports · doi:10.1038/s41598-017-06240-w · Cited by 22
Xu, P., Xu, S., He, C., & Khetan, A. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107577 · Cited by 20
Protein Secretion Systems of Corynebacterium glutamicum
Vertès, A. A. (2012) · Microbiology monographs · doi:10.1007/978-3-642-29857-8_13 · Cited by 22
“For example, insect and mammalian cells are mostly used to produce high value-added products such as pharmaceuticals considering the resulting high manufacturing costs (Schmidt 2004; Wurm 2004).”
BackgroundRobust Cell Line Development Using Meganucleases
Cabaniols, J., & Pâques, F. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-232-8_3 · Cited by 20
“6 cell line, stably transfected with the gene of interest (22).”
BackgroundChen, F., Li, F., Wang, J., Zhou, Y., Ye, Z., Zhao, L., & Tan, W. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3484-z · Cited by 20
“Consequently, the intracellular LC was significantly in excess to HC, and this disproportionate expression of IgG chains may be a disadvantage for mAb production (Trill et al. 1995).”
BackgroundDahodwala, H., Nowey, M., Mitina, T., & Sharfstein, S. T. (2011) · Cytotechnology · doi:10.1007/s10616-011-9388-z · Cited by 26
“gies to achieve higher viable cell densities and extended growth phases (Wurm 2004).”
BackgroundYamano, N., Takahashi, M., Haghparast, S. M. A., Onitsuka, M., Kumamoto, T., Frank, J., & Ōmasa, T. (2016) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2016.01.002 · Cited by 21
Langreder, N., Schäckermann, D., Meier, D., Becker, M., Schubert, M., Dübel, S., Reinard, T., Figge-Wegener, S., Roßbach, K., Bäumer, W., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-31173-y · Cited by 19
Ong, H. K., Nguyen, N., Bi, J., & Yang, Y. (2022) · Antibody Therapeutics · doi:10.1093/abt/tbac025 · Cited by 21
“Chinese hamster ovary (CHO) cells are the dominant host cells for producing therapeutic antibodies due to their advantages of robust cell growth and capability of performing proper post-translational modifications [11].”
BackgroundIMAC capture of recombinant protein from unclarified mammalian cell feed streams
Kinna, A., Tolner, B., Miranda, E., Titchener-Hooker, N. J., Nesbeth, D., & Chester, K. A. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25705 · Cited by 21
“KEYWORDS: radial flow chromatography; downstream processing; IMAC; recombinant protein; integrated processing; Chinese hamster ovary cells”
BackgroundMethodGeneration of a Chinese Hamster Ovary Cell Line Producing Recombinant Human Glucocerebrosidase
Novo, J. B., Morganti, L., Moro, A. M., Leme, A. F. P., Serrano, S. M. T., Raw, I., & Ho, P. L. (2012) · BioMed Research International · doi:10.1155/2012/875383 · Cited by 20
“This is a well-characterized expression system [28, 29], commonly used in the biopharmaceutical industry for the production of glycoproteins [30, 31].”
BackgroundMayrhofer, P., Kratzer, B., Sommeregger, W., Steinfellner, W., Reinhart, D., Mäder, A., Turan, S., Qiao, J., Bode, J., & Kunert, R. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-6011-1 · Cited by 22
“The main producers for all therapeutic proteins are Chinese hamster ovary (CHO) cells because of their human-like protein expression capabilities, authentic glycosylation patterns, ease of cultivation, and genetic modification (Wurm 2004).”
Backgroundde Sousa, S. F., Bastin, G., Jolicœur, M., & Wouwer, A. V. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25879 · Cited by 22
Xiao, Z., Sabourin, M., Piras, G., & Gorfien, S. F. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-733-4_9 · Cited by 19
Fed-Batch CHO Cell Culture for Lab-Scale Antibody Production
Fan, Y., Ley, D., & Andersen, M. R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7312-5_12 · Cited by 28
Gupta, S. K., Sharma, A., Kushwaha, H., & Shukla, P. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00463 · Cited by 21
“Glycosylation pattern of monoclonal antibodies and other glycoproteins can be altered by the ammonia accumulation (Borys et al., 1994; Andersen and Goochee, 1995; Gawlitzek et al., 2000; Yang and Butler, 2002; Chen and Harcum, 2006).”
Background
Metadata
- Authors
- Wurm, F. M.
- Affiliations
- École Polytechnique Fédérale de Lausanne (CH)
- Corresponding author
- Wurm, Florian M
- ORCID
- Wurm, Florian M
- Venue
- Nature Biotechnology
- Published
- 2004-11
- Volume
- 22
- Issue
- 11
- Pages
- 1393-1398
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2118540273
- Cited by
- 2,032
- References
- 52
- Citations by year
- 2026: 52 · 2025: 51 · 2024: 66 · 2023: 66 · 2022: 64 · 2021: 77 · 2020: 89 · 2019: 114 · 2018: 162 · 2017: 118 · 2016: 95 · 2015: 135 · 2014: 108 · 2013: 145 · 2012: 111
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Transgenic Plants and Applications
- Keywords
- recombinant therapeutic proteins, mammalian cell culture, bioreactors, protein folding, post-translational modification, volumetric productivity, culture medium optimization, process control, vector engineering, host cell engineering
- MeSH terms
- Animals, Cells, Cultured, Humans, Mammals, Recombinant Proteins, Transfection, Protein Engineering, Cell Culture Techniques, Bioreactors, Genetic Enhancement
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.